Research and Development (R&D)
Pohl-Boskamp is constantly extending its range with fast-acting products; the benefits of which the patient can actually feel. In so doing, we have opened out into totally new therapeutic indications over the last few years. As we possess all key skills fundamental to the pharmaceutical industry, we are able to meet and maintain the high standards demanded of our product range.
As a medium-sized company, we focus our R&D strengths on developing and perfecting pharmaceutical forms of already “tried and tested” substances. Thus, by combining science and daily patient routine, the use of medications is made simpler, safer and more pleasant. Consequently, results from research are just as important to us as experience from clinical practice, which we document and evaluate by means of continuous exchange with patients, their doctors and pharmacists.
Since the introduction of new European legislation governing medical devices, this particular sector is now a main focus of our R&D activities, as we are now able to take advantage of distributing our products throughout Europe.
Furthermore, in the interests of our product range, we also play an active role in the global exchange of ideas, thereby ensuring that we are extremely well-placed on the international market for obtaining product licences.
At Pohl-Boskamp, the scope of scientific activities performed on medicinal products and medical devices extends far beyond that needed to obtain marketing approval. We dedicate a vast amount of time and effort to the field of clinical research, in order to demonstrate the efficary and safety of our products according to the latest principles of evidence-based medicine.
Obviously, such commitment requires highly developed skills in the field of business development, preclinical and clinical research, as well as regulatory affairs.